Top Markets
Coin of the day
Dechra Pharmaceuticals PLC Dechra Pharmaceuticals PLC

Dechra Pharmaceuticals PLC

DPH
Rank in Stocks #24496
Dechra Pharmaceuticals PLC is a veterinary-focused enterprise dedicated to the... Dechra Pharmaceuticals PLC is a veterinary-focused enterprise dedicated to the development, production, regulatory approval, marketing, and distribution of animal health products and associated goods for veterinarians. The company's activities are organized across three key segments: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceutical Research and Development. It supplies a broad range of veterinary treatments, encompassing endocrinology, dermatology, pain management and anesthetics, cardiovascular therapies, and critical care solutions for dogs and cats. For poultry, pigs, and cattle, offerings include water-soluble antibiotics, avian vaccines, and pain relief products. Equine health is addressed with products for lameness and pain. Furthermore, Dechra offers specialized pet nutrition designed to support therapeutic conditions in cats and dogs, such as allergies, obesity, and heart or kidney diseases. Its diversified operations also involve the distribution of veterinary pharmaceuticals and equipment, the provision of financial services, the promotion of pet food, and the creation, regulation, manufacturing, and commercialization of crop protection items. The company’s merchandise is primarily channeled to customers via extensive wholesaler and distributor networks. Founded in 1997 and headquartered in Northwich, UK, Dechra Pharmaceuticals PLC operates globally, with a significant presence in the United Kingdom, Germany, across Europe, the United States, and international markets.
Share Price
$52.60
Last synced: 2024-01-15
Market Cap
$59.92M
Change (1 day)
6.81%
Change (1 year)
0.00%
Country
GB
Trade Dechra Pharmaceuticals PLC (DPH)

Category

Stock price history for Dechra Pharmaceuticals PLC (DPH)
Highest end of day price: $49.42 on 2024-01-01

Lowest end of day price: $1.84 on 2000-09-01
Stock price history of Dechra Pharmaceuticals PLC from 2000 to 2026
Annual Stock Price Performance
Year Performance
2024 1.63%
2023 47.41%
2022 -50.83%
2021 50.16%
2020 20.78%
2019 37.93%
2018 -2.56%
2017 70.50%
2016 4.52%
2015 22.57%
2014 13.00%
2013 14.98%
2012 36.14%
2011 -2.44%
2010 6.10%
2009 45.85%
2008 -26.40%
2007 43.29%
2006 10.69%
2005 28.75%
2004 58.45%
2003 17.30%
2002 -22.48%
2001 -7.48%
2000 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$1.26K 77.31%
US
$271.21 51.57%
US
$265.96 26.95%
US
$493.69 45.48%
CH
$152.61 77.29%
US